What Does the FDA Think About In Silico Evidence?
One of the most common questions we get and a question that keeps coming up in cardiovascular device development circles, in regulatory affairs meetings, and in conversations between engineers who have just run their first digital twin simulation is “Will the FDA actually accept this?” It’s a fair question. And …
What Does the FDA Think About In Silico Evidence? Read More »











